KRAS and colorectal carcinoma: In the present series, which included 729 patients with advanced CRC, only two cases with intratumoral variability of the mutation status (coexistence of mutations in KRAS exons 2 and 3; G12D + Q61L and G13V +Q61L) were identified, accounting for the 0.3% of all examined cases.